dsdsa

product

2020 China New Design Mesylate-Azd9291 - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

Persisting in "High good quality, Prompt Delivery, Aggressive Price", we've established long-term cooperation with shoppers from each overseas and domestically and get new and previous clients' high comments for 15307-79-6, 209216-23-9, Entecavir, We sincerely welcome overseas customers to consult for the long-term cooperation and the mutual development.We strongly believe that we can do better and better.
2020 China New Design Mesylate-Azd9291 - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai Detail:

Product name Cabazitaxel
Synonyms (αR,βS)-β-[[(1,1-DiMethylethoxy)carbonyl]aMino]-α-hydroxybenzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-diMethoxy-4a,8,13,13-tetraMethyl-5-oxo-7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester
CAS No. 183133-96-2
Appearance White to almost white crystalline solid
Molecular Formula C45H57NO14
Molecular Weight 835.93
Application Pharma grade or research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Cabazitaxel CAS:183133-96-2

ITEMS STANDARDS RESULTS
CHARACTERISTICS White to almost white crystalline solid White crystalline solid
IDENTIFICATION Should to positive Positive
SOUBILITY Freely soluble in Acetone and Dichloromethane,Soluble in Ethanol and Methanol, Sparingly soluble in Ethyl acetate. Complies
LOSS ON DRYING ≤1.0% 0.1%
RESIDUE ON IGNITION ≤0.2% 0.05%
HEAVY METALS ≤20ppm Complies
RELATIVE SUBSTANCE Single impurity:≤0.3% 0.08%
Total Impurities:≤0.8 % 0.19%
RESIDUAL SOLVENT Tetrahydrofuran:≤0.072%Methanol: ≤0.3%

Dichloromethane:≤0.06%

Ethyl Acetate: ≤0.5%

Not DetectedNot Detected

Not Detected

Not Detected

ASSAY NLT 98.5% 99.78%
Conclusion:It complies to prescribed enterprise standard

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

2020 China New Design Mesylate-Azd9291 - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai detail pictures

2020 China New Design Mesylate-Azd9291 - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai detail pictures

2020 China New Design Mesylate-Azd9291 - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai detail pictures


Related Product Guide:

Our advancement depends over the superior machines, exceptional talents and continually strengthened technology forces for 2020 China New Design Mesylate-Azd9291 - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai , The product will supply to all over the world, such as: Macedonia, Australia, Albania, After years' creating and developing, with the advantages of trained qualified talents and rich marketing experience, outstanding achievements were gradually made. We get good reputation from the customers due to our good solutions quality and fine after-sale service. We sincerely wish to create a more prosperous and flourishing future together with all the friends home and abroad!
  • High Quality, High Efficiency, Creative and Integrity, worth having long-term cooperation! Looking forward to the future cooperation!
    5 Stars By Deirdre from Tunisia - 2018.09.21 11:01
    The customer service staff is very patient and has a positive and progressive attitude to our interest, so that we can have a comprehensive understanding of the product and finally we reached an agreement, thanks!
    5 Stars By Fernando from Canada - 2018.06.30 17:29
    Write your message here and send it to us